Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-Q for the period ended Jun 30, 2014

Filed with the SEC on Aug 18, 2014 and accepted by EDGAR at Aug 18, 2014, 18:32 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-04-01 to 2014-06-30$303us-gaap:SalesRevenueNet
Revenue6 months2014-01-01 to 2014-06-30$468us-gaap:SalesRevenueNet
Gross profit3 months2014-04-01 to 2014-06-30$303us-gaap:GrossProfit
Gross profit6 months2014-01-01 to 2014-06-30$468us-gaap:GrossProfit
Operating income3 months2014-04-01 to 2014-06-30−$16.0kus-gaap:OperatingIncomeLoss
Operating income6 months2014-01-01 to 2014-06-30−$19.9kus-gaap:OperatingIncomeLoss
Net income3 months2014-04-01 to 2014-06-30−$16.0kus-gaap:NetIncomeLoss
Net income6 months2014-01-01 to 2014-06-30−$20.2kus-gaap:NetIncomeLoss
Diluted EPS3 months2014-04-01 to 2014-06-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2014-01-01 to 2014-06-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2014-01-01 to 2014-06-30$155us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash and equivalentsAt period end2014-06-30$680us-gaap:Cash
Current assetsAt period end2014-06-30$680us-gaap:AssetsCurrent
Total assetsAt period end2014-06-30$680us-gaap:Assets
Current liabilitiesAt period end2014-06-30$20.1kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-06-30$20.1kus-gaap:Liabilities
Shareholders' equityAt period end2014-06-30−$19.4kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-14-051039. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.